ALLR vs CARR · P/E 0.0, rev $25.0K vs P/E 43, rev $21.75B
Allarity Therapeutics Inc (ALLR) versus Carrier Global Corp (CARR) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Not investment advice. Open the ALLR and CARR stock pages for the full models.
Not investment advice.